SCA
ARNA

SAC Capital Advisors’s Arena Pharmaceuticals Inc ARNA Stock Holding History

SAC Capital Advisors’s Portfolio ARNA Stock Details ARNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q3 		– Sell
-1,310
Closed -$101K – 1991
2013
Q2 		$101K Buy
+1,310
New +$107K ﹤0.01% 1551

Other funds holding ARNA

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

SAC Capital Advisors's ARNA Position: Q3 2013 in Review

SAC Capital Advisors sold out of Arena Pharmaceuticals Inc (ARNA) in Q3 2013, closing a stake of 1,310 shares — an estimated $101K sold.

SAC Capital Advisors first reported a position in ARNA in Q2 2013 and held it in 1 quarter. The position peaked at $101K in Q2 2013. 140 funds tracked by Wall St. Rank hold ARNA as of Q3 2013.

  • SAC Capital Advisors reported no remaining Arena Pharmaceuticals Inc position as of Q3 2013 after selling out during the quarter.
  • SAC Capital Advisors sold 1,310 Arena Pharmaceuticals Inc shares in Q3 2013, an estimated $101K.
  • SAC Capital Advisors first reported a position in Arena Pharmaceuticals Inc in Q2 2013 and held it in 1 quarter.
  • SAC Capital Advisors's Arena Pharmaceuticals Inc position peaked at $101K in Q2 2013.
  • 140 funds tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q3 2013.

Based on SAC Capital Advisors's 13F filing for Q3 2013, filed 14 Nov 2013.